Canada's Rx&D association appoints GSK head as chair
This article was originally published in SRA
Executive Summary
Paul Lucas has been appointed chair of the board of directors of Canadian industry association Research-Based Pharmaceutical Companies (Rx&D). Mr Lucas, the president and chief executive officer of GlaxoSmithKline in Canada, is a member of Rx&D's executive committee and has been vice chair of the board of directors; he was also previously appointed chair in 1999 and 2006.